Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 14.05.2018 1 Aliment Pharmacol Ther 1 Clin Exp Immunol 1 Dig Dis 1 Dig Dis Sci 4 Dis Colon Rectum 1 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 5 Gastroenterology 1 Gut 3 Inflamm Bowel Dis 4 J Crohns Colitis 1 Lancet Gastroenterol Hepatol 1 PLoS One 2 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. SACLEUX SC, Sarter H, Fumery M, Charpentier C, et al
   Post-operative complications in elderly onset inflammatory bowel disease: a population-based study.
   Aliment Pharmacol Ther. 2018 May 8. doi: 10.1111/apt.14790.
   PubMed     Text format     Abstract available
   
   

   
   Clin Exp Immunol

2. WEDER B, Mozaffari M, Biedermann L, Mamie C, et al
   BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice.
   Clin Exp Immunol. 2018 May 10. doi: 10.1111/cei.13151.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis

3. CUOMO A, Sgambato D, D'Auria MV, Miranda A, et al
   Multi Matrix System Mesalazine Plus Rectal Mesalazine in the Treatment of Mild to Moderately Active Ulcerative Proctitis.
   Dig Dis. 2018;36:130-135.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

4. WEIZMAN AV, Sharma R, Afzal NM, Xu W, et al
   Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
   Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5096.
   PubMed     Text format     Abstract available
   
   

   
   Dis Colon Rectum

5. ALI F, Al-Kindi SG, Blank JJ, Peterson CY, et al
   Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery.
   Dis Colon Rectum. 2018;61:375-381.
   PubMed     Text format     Abstract available
   
   
6. LIU W, Zhou W, Xiang J, Cao Q, et al
   Lemann Index at Diagnosis Predicts the Risk of Early Surgery in Crohn's Disease.
   Dis Colon Rectum. 2018;61:207-213.
   PubMed     Text format     Abstract available
   
   
7. RUSSELL TA, Dawes AJ, Graham DS, Angarita SAK, et al
   Rescue Diverting Loop Ileostomy: An Alternative to Emergent Colectomy in the Setting of Severe Acute Refractory IBD-Colitis.
   Dis Colon Rectum. 2018;61:214-220.
   PubMed     Text format     Abstract available
   
   
8. LIGHTNER AL
   Perioperative Management of Biologic and Immunosuppressive Medications in Patients With Crohn's Disease.
   Dis Colon Rectum. 2018;61:428-431.
   PubMed     Text format    
   
   

   
   Eur J Gastroenterol Hepatol

9. CHAN W, Lynch N, Bampton P, Chang J, et al
   Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.
   Eur J Gastroenterol Hepatol. 2018 Apr 30. doi: 10.1097/MEG.0000000000001150.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterol Hepatol

10. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

11. ROY S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, et al
    Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
    Gastroenterology. 2018;154:1405-1420.
    PubMed     Text format     Abstract available
    
    
12. SIMURINA M, de Haan N, Vuckovic F, Kennedy NA, et al
    Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;154:1320-1333.
    PubMed     Text format     Abstract available
    
    
13. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1334-1342.
    PubMed     Text format     Abstract available
    
    
14. D'HAENS G, Vermeire S, Lambrecht G, Baert F, et al
    Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
    Gastroenterology. 2018;154:1343-1351.
    PubMed     Text format     Abstract available
    
    
15. UHLIG HH, Booth C
    Inflammatory Bowel Disease and Immune Defects: A Spectrum of Genetic Variants and Clinical Pathogenicity.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34485.
    PubMed     Text format    
    
    

    
    Gut

16. ZEISSIG S, Rosati E, Dowds CM, Aden K, et al
    Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
    Gut. 2018 May 5. pii: gutjnl-2018-316023. doi: 10.1136/gutjnl-2018-316023.
    PubMed     Text format     Abstract available
    
    

    
    Inflamm Bowel Dis

17. MOON CM, Kim SW, Ahn JB, Ma HW, et al
    Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.
    Inflamm Bowel Dis. 2018 May 4. pii: 4992873. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
18. ROBLIN X, Riviere P, Flamant M, Veyrard P, et al
    Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 3. pii: 4992140. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
19. WENG MT, Park SH, Matsuoka K, Tung CC, et al
    Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Inflamm Bowel Dis. 2018 May 3. pii: 4991928. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Crohns Colitis

20. TSE CS, Deepak P, De La Fuente J, Bledsoe AC, et al
    Phenotype and Clinical Course of Inflammatory Bowel Disease with Co-Existent Celiac Disease.
    J Crohns Colitis. 2018 May 7. pii: 4993346. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
21. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Burakoff R, et al
    The Impact of Opioid Epidemic Trends on Hospitalized Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2018 May 7. pii: 4993358. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
22. FOBELO LOZANO MJ, Serrano Gimenez R, Castro Fernandez M
    Emergence of Inflammatory Bowel Disease During Treatment with Secukinumab.
    J Crohns Colitis. 2018 May 9. pii: 4994228. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
23. GARG M, Hendy P, Ding JN, Shaw S, et al
    The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis.
    J Crohns Colitis. 2018 May 3. pii: 4991883. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

24. POUILLON L, Laurent V, Pouillon M, Bossuyt P, et al
    Diffusion-weighted MRI in inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2018;3:433-443.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. WALJEE AK, Wiitala WL, Govani S, Stidham R, et al
    Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    PLoS One. 2018;13:e0197341.
    PubMed     Text format     Abstract available
    
    

    
    Z Gastroenterol

26. SCHNEIDER A, Hirth M, Weiss C, Weidner P, et al
    Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis.
    Z Gastroenterol. 2018;56:469-478.
    PubMed     Text format     Abstract available
    
    
27. HUPPE A, Langbrandtner J, Hauser W, Raspe H, et al
    Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis.
    Z Gastroenterol. 2018 May 9. doi: 10.1055/a-0605-4080.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: